Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Global Cord Blood stock
Learn how to easily invest in Global Cord Blood stock.
Global Cord Blood Corp is a diagnostics & research business based in the US. Global Cord Blood shares (CO) are listed on the NYSE and all prices are listed in US Dollars. Global Cord Blood employs 1,215 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Global Cord Blood
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Global Cord Blood stock price (NYSE: CO)Use our graph to track the performance of CO stocks over time.
Global Cord Blood shares at a glance
|Latest market close||$3.00|
|52-week range||$2.10 - $5.50|
|50-day moving average||$2.91|
|200-day moving average||$3.88|
|Wall St. target price||$15.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.64|
Buy Global Cord Blood shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Global Cord Blood stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Global Cord Blood price performance over time
|1 week (2022-06-28)||-5.66%|
|1 month (2022-06-03)||-13.29%|
|3 months (2022-04-05)||-23.47%|
|6 months (2022-01-05)||-34.07%|
|1 year (2021-07-02)||-44.34%|
|2 years (2020-07-02)||0.33%|
|3 years (2019-07-05)||5.72|
|5 years (2017-07-05)||9.79|
Is Global Cord Blood stock undervalued or overvalued?
Valuing Global Cord Blood stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Cord Blood's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Global Cord Blood's P/E ratio
Global Cord Blood's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Global Cord Blood shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Global Cord Blood's EBITDA
Global Cord Blood's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $663.8 million.
The EBITDA is a measure of a Global Cord Blood's overall financial performance and is widely used to measure a its profitability.
Global Cord Blood financials
|Revenue TTM||$1.2 billion|
|Operating margin TTM||49.26%|
|Gross profit TTM||$980.7 million|
|Return on assets TTM||4.77%|
|Return on equity TTM||11.78%|
|Market capitalisation||$364.7 million|
TTM: trailing 12 months
Global Cord Blood share dividends
We're not expecting Global Cord Blood to pay a dividend over the next 12 months.
Global Cord Blood share price volatility
Over the last 12 months, Global Cord Blood's shares have ranged in value from as little as $2.1 up to $5.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Global Cord Blood's is 0.4065. This would suggest that Global Cord Blood's shares are less volatile than average (for this exchange).
Global Cord Blood overview
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd. .
Global Cord Blood in the news
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation
Frequently asked questionsWhat percentage of Global Cord Blood is owned by insiders or institutions?
Currently 73.248% of Global Cord Blood shares are held by insiders and 16.598% by institutions. How many people work for Global Cord Blood?
Latest data suggests 1,215 work at Global Cord Blood. When does the fiscal year end for Global Cord Blood?
Global Cord Blood's fiscal year ends in March. Where is Global Cord Blood based?
Global Cord Blood's address is: Bank of China Tower, Central, Hong Kong What is Global Cord Blood's ISIN number?
Global Cord Blood's international securities identification number is: KYG393421030 What is Global Cord Blood's CUSIP number?
Global Cord Blood's Committee on Uniform Securities Identification Procedures number is: 698659109
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert